Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Salivary glands tumors have numerous entities and each tumor type is of wide histologic spectrum. Clinical presentation is not particularly helpful, with the usual presentation of a bump. The growth pattern of the tumor is a very critical histologic feature. If it is invasive and destructive, the tumor is very likely to be malignant. If it is well circumscribed/well demarcated, it is either a benign or a low grade tumor. Based on the presence of one cell type (luminal or non-luminal alone) or mixed luminal and non-luminal cell component (with an obvious extracellular matrix or not), we can classify most of the salivary gland tumors. Fine needle aspiration has been very useful in screening lesions with minimal trauma. However, previous FNA procedures can induce squamous metaplasia and tissue infarction, which sometimes misleads the pathologist. The metaplastic change also can mimic a low-grade mucoepidermoid carcinoma. On the other hand, a low-grade carcinoma such as cystic mucoepidermoid carcinoma is easily misdiagnosed a benign lesion, due to unimpressive bland cytological features. Immunohistochemistry studies are valuable when used along with histology; the main application is to demonstrate the cellular differentiation. Modern molecular tools such as FISH are important in separating those tumors with overlapping morphology. Translocations are found in adenoid cystic carcinoma (49%, MYB-NFIB), low and intermediate grade mucoepidermoid carcinoma (55%, CRTC1-MAML2), low-grade hyalinizing clear cell carcinoma (>80%, EWSR1-ATF1), and secretory carcinoma (>90%, ETV6-NTRK3). It is more stressful when we handle salivary gland tumors intraoperatively, because of the freezing artifacts and limited time, as well as the unavailability of ancillary tools. The combination of tumor demarcation, cell types, and cytological features can lead to correct diagnoses for most cases. For those rare and difficult cases, separating benign/low grade from high-grade tumors is usually sufficient to guide the immediate surgical procedure
Biography
Qihui Zhai is a Pathologist at Mayo Clinic. He received his Medical degree from Shandong Medical University and has been in practice for more than 20 years. He is one of 13 doctors at Mayo Clinic who has specialization in Pathology.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals